Publications by authors named "Prasarn Manitpisitkul"

Claim this Profile
B
Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies.
Prasarn Manitpisitkul, Kevin Shalayda, Lucille Russell, Panna Sanga, Yinka Williams

Clin Pharmacol Drug Dev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Mavatrep (JNJ-39439335), a TRPV1 Antagonist in Healthy Japanese and Caucasian Men: A Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Phase 1 Study.
Prasarn Manitpisitkul, Kevin Shalayda, Lucille Russell, Panna Sanga, Bhavna Solanki

Clin Pharmacol Drug Dev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep).
Prasarn Manitpisitkul, Christopher M Flores, John A Moyer, Gary Romano, Kevin Shalayda

Scand J Pain· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
Damayanthi Devineni, Prasarn Manitpisitkul, Joseph Murphy, Donna Skee, Ewa Wajs

Clin Pharmacol Drug Dev· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis.
Arthur J Mayorga, Christopher M Flores, Jeremiah J Trudeau, John A Moyer, Kevin Shalayda, Prasarn Manitpisitkul

Scand J Pain· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study.
Prasarn Manitpisitkul, Michael Brandt, Christopher M Flores, Velga Kenigs, John A Moyer

Pain Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, and assessment of dose proportionality in healthy participants.
Damayanthi Devineni, Prasarn Manitpisitkul, Joseph Murphy, Hans Stieltjes, Jay Ariyawansa

Clin Pharmacol Drug Dev· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men.
Prasarn Manitpisitkul, Arthur Mayorga, Kevin Shalayda, Marc De Meulder, Gary Romano

Clin Drug Investig· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
Damayanthi Devineni, Prasarn Manitpisitkul, Nicole Vaccaro, Apexa Bernard, Donna Skee

Int J Clin Pharmacol Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
Prasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford

Epilepsy Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
Prasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford

Clin Pharmacol Drug Dev· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment.
Prasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford

Epilepsy Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label drug-drug interaction study of the steady-state pharmacokinetics of topiramate and glyburide in patients with type 2 diabetes mellitus.
Prasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford

Clin Drug Investig· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Prasarn Manitpisitkul, Kevin Shalayda, Mike Todd, Shean S Wang, Seth Ness

Epilepsia· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humans.
Troy C Sarich, Margery A Connelly, Dorota B Schranz, Atalanta Ghosh, Prasarn Manitpisitkul

Int J Clin Pharmacol Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures.
Vinay Puri, Seth Ness, Sita Jayalakshmi Sattaluri, Steven Wang, Mike Todd, Prasarn Manitpisitkul

J Child Neurol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Stephan Schmidt, Sreedharan Nair Sabarinath, April Barbour, Darren Abbanat, Prasarn Manitpisitkul

Antimicrob Agents Chemother· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ studies of regional absorption of lobucavir and ganciclovir from rabbit intestine and predictions of dose-limited absorption and associated variability in humans.
Zheng Yang, Prasarn Manitpisitkul, Ronald J Sawchuk

J Pharm Sci· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
Bruce Prenner, Kenneth Kim, Samir Gupta, Sauzanne Khalilieh, Bhavna Kantesaria, Prasarn Manitpisitkul

Expert Opin Drug Saf· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whatever happened to cassette-dosing pharmacokinetics?
Prasarn Manitpisitkul, Ronald E White

Drug Discov Today· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteers.
Gail S Itokazu, James H Fischer, Prasarn Manitpisitkul, Radhika Hariharan, Larry H Danziger

Pharmacotherapy· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis